Search Results - "Yao, Zi W."

Multicomponent Bioluminescence Imaging with Naphthylamino Luciferins by Brennan, Caroline K., Ornelas, Marya Y., Yao, Zi W., Prescher, Jennifer A.

“…Bioluminescent tools have been used for decades to image processes in complex tissues and preclinical models. However, few distinct probes are available to…”
Get full text

Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase by Hurley, Katherine A, Santos, Thiago M A, Fensterwald, Molly R, Rajendran, Madhusudan, Moore, Jared T, Balmond, Edward I, Blahnik, Brice J, Faulkner, Katherine C, Foss, Marie H, Heinrich, Victoria A, Lammers, Matthew G, Moore, Lucas C, Reynolds, Gregory D, Shearn-Nance, Galen P, Stearns, Brian A, Yao, Zi W, Shaw, Jared T, Weibel, Douglas B

“…Bacterial DNA gyrase is an essential type II topoisomerase that enables cells to overcome topological barriers encountered during replication, transcription,…”
Get full text

Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyraseThe authors declare no competing interests.The authors declare no competing financial interest.Electronic supplementary information (ESI) available: Tables, figures, bacterial strain information and compound purity data. See DOI: 10.1039/c7md00012j by Hurley, Katherine A, Santos, Thiago M. A, Fensterwald, Molly R, Rajendran, Madhusudan, Moore, Jared T, Balmond, Edward I, Blahnik, Brice J, Faulkner, Katherine C, Foss, Marie H, Heinrich, Victoria A, Lammers, Matthew G, Moore, Lucas C, Reynolds, Gregory D, Shearn-Nance, Galen P, Stearns, Brian A, Yao, Zi W, Shaw, Jared T, Weibel, Douglas B

“…Bacterial DNA gyrase is an essential type II topoisomerase that enables cells to overcome topological barriers encountered during replication, transcription,…”
Get full text

Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase† †The authors declare no competing interests. ‡ ‡The authors declare no competing financial interest. § §Electronic supplementary information (ESI) available: Tables, figures, bacterial strain information and compound purity data. See DOI: 10.1039/c7md00012j by Hurley, Katherine A., Santos, Thiago M. A., Fensterwald, Molly R., Rajendran, Madhusudan, Moore, Jared T., Balmond, Edward I., Blahnik, Brice J., Faulkner, Katherine C., Foss, Marie H., Heinrich, Victoria A., Lammers, Matthew G., Moore, Lucas C., Reynolds, Gregory D., Shearn-Nance, Galen P., Stearns, Brian A., Yao, Zi W., Shaw, Jared T., Weibel, Douglas B.

“…New gyramide antibiotics with reduced drug efflux and improved antibiotic activity against pathogenic bacteria. Bacterial DNA gyrase is an essential type II…”
Get full text